BofA upgraded Hims & Hers to Neutral from Underperform with a price target of $23, up from $12.50.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers price target raised to $28 from $25 at Deutsche Bank
- Citi upgrades Hims & Hers to Neutral on Novo pact renewal
- Hims & Hers upgraded to Neutral from Sell at Citi
- Needham Upgrades Hims & Hers Stock (HIMS) after Novo Nordisk Deal Resets Weight Loss Outlook
- Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!